SARS-CoV-2-related Multisystem Inflammatory Syndrome in Adult complicated by myocarditis and cardiogenic shock.
Maarten A J De SmetJ FierensL VanhulleY Vande WeygaerdeT L A MalfaitD DevosF HaerynckS GevaertPublished in: ESC heart failure (2022)
Multisystem Inflammatory Syndrome in Adult (MIS-A) is a rare COVID-19 complication, presenting as fever with laboratory evidence of inflammation, severe illness requiring hospitalization and multisystem organ involvement. We report on a 25-year-old man presenting with fever, rash, abdominal pain, diarrhoea and vomiting following prior asymptomatic COVID-19 infection. He developed refractory shock and type 1 respiratory insufficiency requiring mechanical ventilation. Diagnostic testing revealed significant inflammation, anemia, thrombocytopenia, acute kidney injury, hepatosplenomegaly, colitis, lymphadenopathy and myocarditis necessitating inotropy. Ventilatory, vasopressor and inotropic support was weaned following pulse corticosteroids and intravenous immunoglobulins. Heart failure therapy was started. Short-term follow-up shows resolution of inflammation and cardiac dysfunction.
Keyphrases
- oxidative stress
- sars cov
- mechanical ventilation
- abdominal pain
- heart failure
- acute kidney injury
- case report
- coronavirus disease
- intensive care unit
- acute respiratory distress syndrome
- left ventricular
- respiratory syndrome coronavirus
- cardiac surgery
- chronic kidney disease
- blood pressure
- single cell
- early onset
- high dose
- atrial fibrillation
- respiratory failure
- low dose
- childhood cancer
- bone marrow
- irritable bowel syndrome
- cell therapy
- chemotherapy induced